DiaMedica Therapeutics, Inc.

  • Home
  • Our Focus
    • Overview
    • Literature & Publications
  • Pipeline
    • Overview
    • Acute Ischemic Stroke
    • Cardio-Renal Disease
  • Clinical Trials
    • Overview
    • Acute Ischemic Stroke
  • ReMEDy2
    • Overview
    • About ReMEDy2
    • Stroke Disease
    • For Physicians
    • Trial Locations
  • About DiaMedica
    • Overview
    • Leadership
    • Careers
    • Contact
  • Investors Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Data
    • Analyst Coverage
    • Financial Reports & SEC Filings
    • Governance
    • Resources

Press Releases

Investors Relations

Investors Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Data
    • Nasdaq Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • Financial Reports & SEC Filings
    • SEC Filings
    • Annual Reports
    • Tax Information (PFIC)
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • Investor Contact
    • FAQ
    • Share Consolidation Instructions
    • Email Alerts
Sep 14, 2020 9:15am EDT

DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study

Aug 11, 2020 4:05pm EDT

DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results

Aug 10, 2020 4:05pm EDT

DiaMedica Announces Closing of $23 Million Public Offering of Common Shares

Aug 06, 2020 4:05pm EDT

DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020

Aug 06, 2020 9:05am EDT

DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares

Aug 05, 2020 4:01pm EDT

DiaMedica Announces Proposed Public Offering of Common Shares

May 19, 2020 4:42pm EDT

DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020

May 13, 2020 4:41pm EDT

DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study

May 13, 2020 4:40pm EDT

DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results

May 07, 2020 4:30pm EDT

DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020

  • Previous
  • 1…
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2023 DiaMedica Therapeutics, Inc. All Rights Reserved.
Twitter LinkedIn
Privacy Policy Disclaimer Sitemap